Product Spotlight: Aniara Diagnostica would like to announce the availability of Biophen™ FXIII

Share Article

Aniara Diagnostica is pleased to announce the availability of Biophen™ FXIII chromogenic method for determination of FXIII

News Image
The entire Aniara line is available for purchase at http://www.aniara.com.

Aniara Diagnostica is pleased to announce the availability of Biophen™ FXIII chromogenic method for determination of FXIII.

Aniara Diagnostica, a multi-national distributor of diagnostic and research agents, as well as screening tools, has strengthened its commitment to meeting today’s highest standards for product quality and cost-efficient delivery.

For Research Use Only. Not for Use in Diagnostic Procedures.

BIOPHEN™ Factor XIII kit is a chromogenic method proposed for in vitro quantitative determination of Factor XIII activity in human citrated plasma.

227005 Biophen™ FXIII click here for more information.

The entire Aniara product line is available for purchase at http://www.aniara.com. The Company distributes products in North America, Central America, South America, Sweden, Norway, Denmark, Finland, Lithuania, Latvia, Estonia and Iceland.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Maria Waldron
Visit website